PepGen Inc. (PEPG)
2.52
-0.18
(-6.67%)
USD |
NASDAQ |
Oct 23, 16:00
2.53
+0.01
(+0.40%)
After-Hours: 20:00
PepGen Net Income (Quarterly) : -17.81M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.81M |
| March 31, 2026 | -17.76M |
| December 31, 2025 | -18.34M |
| September 30, 2025 | -18.03M |
| June 30, 2025 | -23.09M |
| March 31, 2025 | -30.20M |
| December 31, 2024 | -22.24M |
| September 30, 2024 | -21.38M |
| June 30, 2024 | -28.34M |
| March 31, 2024 | -18.02M |
| December 31, 2023 | -19.50M |
| September 30, 2023 | -23.29M |
| Date | Value |
|---|---|
| June 30, 2023 | -19.52M |
| March 31, 2023 | -16.32M |
| December 31, 2022 | -14.94M |
| September 30, 2022 | -18.61M |
| June 30, 2022 | -17.32M |
| March 31, 2022 | -18.25M |
| December 31, 2021 | -7.144M |
| September 30, 2021 | -8.112M |
| March 31, 2021 | -6.636M |
| December 31, 2020 | -0.797M |
| September 30, 2020 | -0.337M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 17.81M |
| EPS Diluted (Quarterly) | -0.2574 |
| Enterprise Value | 73.39M |
| Earnings Yield | -51.81% |
| Normalized Earnings Yield | -51.81 |